0001104659-23-112599.txt : 20231030
0001104659-23-112599.hdr.sgml : 20231030
20231030163133
ACCESSION NUMBER: 0001104659-23-112599
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231026
FILED AS OF DATE: 20231030
DATE AS OF CHANGE: 20231030
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Swisher Daniel N JR
CENTRAL INDEX KEY: 0001323113
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37852
FILM NUMBER: 231360754
MAIL ADDRESS:
STREET 1: C/O SUNESIS PHARMACEUTICALS, INC.
STREET 2: 395 OYSTER POINT BLVD., SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc
CENTRAL INDEX KEY: 0001377121
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980505495
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
BUSINESS PHONE: (510) 474-0170
MAIL ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Therapeutics Inc
DATE OF NAME CHANGE: 20130605
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Inc
DATE OF NAME CHANGE: 20061002
4
1
tm2328975-3_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-10-26
0
0001377121
Protagonist Therapeutics, Inc
PTGX
0001323113
Swisher Daniel N JR
C/O PROTAGONIST THERAPEUTICS, INC.
7707 GATEWAY BLVD., SUITE 140
NEWARK
CA
94560-1160
1
0
0
0
0
Stock Option (right to buy)
14.21
2023-10-26
4
A
0
45000
0.00
A
2033-10-26
Common Stock
45000
45000
D
The options vest in 36 equal monthly installments following October 26, 2023, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
/s/ Matthew Gosling, Attorney-in-Fact for Daniel Swisher
2023-10-30